222 related articles for article (PubMed ID: 9734400)
1. Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Saez E; Tontonoz P; Nelson MC; Alvarez JG; Ming UT; Baird SM; Thomazy VA; Evans RM
Nat Med; 1998 Sep; 4(9):1058-61. PubMed ID: 9734400
[TBL] [Abstract][Full Text] [Related]
2. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
Lefebvre AM; Chen I; Desreumaux P; Najib J; Fruchart JC; Geboes K; Briggs M; Heyman R; Auwerx J
Nat Med; 1998 Sep; 4(9):1053-7. PubMed ID: 9734399
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
Sarraf P; Mueller E; Jones D; King FJ; DeAngelo DJ; Partridge JB; Holden SA; Chen LB; Singer S; Fletcher C; Spiegelman BM
Nat Med; 1998 Sep; 4(9):1046-52. PubMed ID: 9734398
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
10. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
[TBL] [Abstract][Full Text] [Related]
11. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.
Shao J; Sheng H; DuBois RN
Cancer Res; 2002 Jun; 62(11):3282-8. PubMed ID: 12036946
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
14. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
Gupta RA; Wang D; Katkuri S; Wang H; Dey SK; DuBois RN
Nat Med; 2004 Mar; 10(3):245-7. PubMed ID: 14758356
[TBL] [Abstract][Full Text] [Related]
16. [The expression of PPAR gamma in gastric cancer].
Morita D; Ichikura T; Mochizuki H
Nihon Rinsho; 2001 Apr; 59 Suppl 4():595-7. PubMed ID: 11424448
[No Abstract] [Full Text] [Related]
17. PPAR--the good news and the bad.
Nat Med; 1998 Sep; 4(9):981. PubMed ID: 9734367
[No Abstract] [Full Text] [Related]
18. [Roles of PPARs in carcinogenesis].
Imamura K; Lu J; Kaminishi M
Nihon Rinsho; 2005 Apr; 63(4):584-8. PubMed ID: 15828224
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma and colorectal carcinoma: conflicts in a nuclear family.
Seed B
Nat Med; 1998 Sep; 4(9):1004-5. PubMed ID: 9734386
[No Abstract] [Full Text] [Related]
20. APC-dependent suppression of colon carcinogenesis by PPARgamma.
Girnun GD; Smith WM; Drori S; Sarraf P; Mueller E; Eng C; Nambiar P; Rosenberg DW; Bronson RT; Edelmann W; Kucherlapati R; Gonzalez FJ; Spiegelman BM
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13771-6. PubMed ID: 12370429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]